Biocon Biologics
Kristine Marshall currently serves as the Associate Director and Quality Assurance Lead at Biocon Biologics, overseeing CMO operations in the US and Canada since June 2023. Prior to this role, Kristine Marshall had a long tenure at Mylan, spanning from October 1993 to July 2021, where leadership responsibilities included directing the Investigations Remediation Team and managing global quality operations. Key achievements include participating in USFDA GMP audits, leading site remediation efforts in India, and acting as a TrackWise Subject Matter Expert while facilitating global trainings and continuous improvement initiatives. Earlier experiences involved significant contributions to product quality assessments and complex pharmaceutical investigations. Kristine Marshall earned a BA in Psychology from West Virginia University.
This person is not in the org chart
This person is not in any offices
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics